These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 15129422

  • 1. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder.
    McRae AL, Brady KT, Mellman TA, Sonne SC, Killeen TK, Timmerman MA, Bayles-Dazet W.
    Depress Anxiety; 2004; 19(3):190-6. PubMed ID: 15129422
    [Abstract] [Full Text] [Related]

  • 2. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT, Clary CM.
    Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
    [Abstract] [Full Text] [Related]

  • 3. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
    Davidson J, Rothbaum BO, Tucker P, Asnis G, Benattia I, Musgnung JJ.
    J Clin Psychopharmacol; 2006 Jun; 26(3):259-67. PubMed ID: 16702890
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of sertraline in posttraumatic stress disorder secondary to interpersonal trauma or childhood abuse.
    Stein DJ, van der Kolk BA, Austin C, Fayyad R, Clary C.
    Ann Clin Psychiatry; 2006 Jun; 18(4):243-9. PubMed ID: 17162624
    [Abstract] [Full Text] [Related]

  • 5. Open trial of nefazodone for combat veterans with posttraumatic stress disorder.
    Garfield DA, Fichtner CG, Leveroni C, Mahableshwarkar A.
    J Trauma Stress; 2001 Jul; 14(3):453-60. PubMed ID: 11534877
    [Abstract] [Full Text] [Related]

  • 6. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
    Baldwin DS, Hawley CJ, Abed RT, Maragakis BP, Cox J, Buckingham SA, Pover GH, Ascher A.
    J Clin Psychiatry; 1996 Jul; 57 Suppl 2():46-52. PubMed ID: 8626363
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial.
    Chung MY, Min KH, Jun YJ, Kim SS, Kim WC, Jun EM.
    Hum Psychopharmacol; 2004 Oct; 19(7):489-94. PubMed ID: 15378676
    [Abstract] [Full Text] [Related]

  • 8. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C, Olivieri L, Di Loreto G, Dionisio P.
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [Abstract] [Full Text] [Related]

  • 9. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 10. Neopterin production in posttraumatic stress disorder before and after pharmacotherapy.
    Atmaca M, Tezcan E, Kuloglu M, Onal S.
    Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):34-6. PubMed ID: 12664311
    [Abstract] [Full Text] [Related]

  • 11. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder.
    Davidson JR, Brady K, Mellman TA, Stein MB, Pollack MH.
    J Clin Psychopharmacol; 2007 Feb; 27(1):85-8. PubMed ID: 17224720
    [Abstract] [Full Text] [Related]

  • 12. An open-label trial of nefazodone in high comorbidity panic disorder.
    DeMartinis NA, Schweizer E, Rickels K.
    J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
    [Abstract] [Full Text] [Related]

  • 13. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study.
    Brenner R, Azbel V, Madhusoodanan S, Pawlowska M.
    Clin Ther; 2000 Apr; 22(4):411-9. PubMed ID: 10823363
    [Abstract] [Full Text] [Related]

  • 14. Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trial.
    Martenyi F, Soldatenkova V.
    Eur Neuropsychopharmacol; 2006 Jul; 16(5):340-9. PubMed ID: 16356696
    [Abstract] [Full Text] [Related]

  • 15. Divalproex in posttraumatic stress disorder: an open-label clinical trial.
    Clark RD, Cañive JM, Calais LA, Qualls CR, Tuason VB.
    J Trauma Stress; 1999 Apr; 12(2):395-401. PubMed ID: 10378177
    [Abstract] [Full Text] [Related]

  • 16. Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder.
    Steiner M, Allgulander C, Ravindran A, Kosar H, Burt T, Austin C.
    Hum Psychopharmacol; 2005 Jan; 20(1):3-13. PubMed ID: 15551351
    [Abstract] [Full Text] [Related]

  • 17. Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale.
    Davidson J, Baldwin DS, Stein DJ, Pedersen R, Ahmed S, Musgnung J, Benattia I, Rothbaum BO.
    Int Clin Psychopharmacol; 2008 Sep; 23(5):299-303. PubMed ID: 18703940
    [Abstract] [Full Text] [Related]

  • 18. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial.
    Pollack MH, Hoge EA, Worthington JJ, Moshier SJ, Wechsler RS, Brandes M, Simon NM.
    J Clin Psychiatry; 2011 Jul; 72(7):892-7. PubMed ID: 21367352
    [Abstract] [Full Text] [Related]

  • 19. An open-label study of mirtazapine as treatment for combat-related PTSD.
    Alderman CP, Condon JT, Gilbert AL.
    Ann Pharmacother; 2009 Jul; 43(7):1220-6. PubMed ID: 19584388
    [Abstract] [Full Text] [Related]

  • 20. Baclofen treatment for chronic posttraumatic stress disorder.
    Drake RG, Davis LL, Cates ME, Jewell ME, Ambrose SM, Lowe JS.
    Ann Pharmacother; 2003 Sep; 37(9):1177-81. PubMed ID: 12921495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.